MENU

CARM Carisma Therapeutics Forecast, Technical & Fundamental Analysis

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma’s proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY772.491.93
+0.25%
State Street® SPDR® S&P 500® ETF
BTC.X63402.434000-149.441400
-0.24%
Bitcoin cryptocurrency
AAPL302.25-2.66
-0.87%
Apple
GME18.54-0.28
-1.49%
GameStop Corp
TSLA327.51-5.30
-1.59%
Tesla
Carisma Therapeutics (CARM) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com